Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study

Peer Review reports

Original Submission
24 Jul 2015	Submitted	Original manuscript
2 Oct 2015	Author responded	Author comments - Rachelle Buchbinder
Resubmission - Version 2
2 Oct 2015	Submitted	Manuscript version 2
Publishing
7 Oct 2015	Editorially accepted
20 Oct 2015	Article published	10.1186/s12891-015-0772-2

Back to article page